Left Atrial Mechanics and Diastolic Function Among People Living With Human Immunodeficiency Virus (from the Veterans

Christopher J Berg1, Bobby Patel1, Maxwell Reynolds1

  • 1Department of Medicine, David Geffen School of Medicine at UCLA, Los Angeles, California; VA Greater Los Angeles Healthcare System, Los Angeles, California.

Insights

People living with HIV (PLWH) on antiretroviral therapy and with viral suppression showed no difference in cardiac mechanics or diastolic dysfunction compared to HIV-uninfected individuals.

Area of Science:

  • Cardiology
  • Infectious Diseases
  • Public Health

Background:

  • Human immunodeficiency virus (HIV) infection is linked to cardiovascular issues, including cardiomyopathy and increased cardiovascular mortality.
  • The impact of HIV on left atrial (LA) mechanics and left ventricular (LV) diastolic function remains under-evaluated, particularly in treated and virally suppressed populations.

Purpose of the Study:

  • To investigate the relationship between LA mechanics, LV diastolic function, and diastolic dysfunction in people living with HIV (PLWH) compared to HIV-uninfected (HIV-) controls.
  • To assess if HIV status influences cardiac function, specifically LA and LV mechanics, in a cohort of veterans without known cardiovascular disease.

Main Methods:

  • A multicenter, cross-sectional cohort analysis of the HIV Cardiovascular Disease substudy of the Veterans Aging Cohort Study database.
  • Echocardiograms from 277 subjects (180 PLWH, 97 HIV-) were analyzed to derive LV and LA phasic strain.
  • Analysis of variance and propensity-weighted ordinal logistic regression were used to assess relationships between LA strain, LV strain, and diastolic dysfunction.

Main Results:

  • No significant differences were observed in LA mechanics or the proportion of diastolic dysfunction between PLWH and HIV- veterans (p = 0.31).
  • HIV status was not associated with the degree of diastolic dysfunction after propensity weighting.
  • In both cohorts, LA reservoir strain and LA conduit strain were inversely and independently associated with the degree of diastolic dysfunction.

Conclusions:

  • Virally suppressed, antiretroviral-treated PLWH did not exhibit differences in LA strain or LV diastolic dysfunction compared to HIV- veterans.
  • HIV viral suppression may potentially mitigate adverse cardiac structural and functional alterations.
  • Further confirmation in diverse cohorts is warranted to solidify the role of viral suppression in cardiovascular health for PLWH.

Related Concept Videos

Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
31
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
37
Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
26
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
45
Heart Failure III: Clinical Manifestations01:26

Heart Failure III: Clinical Manifestations

Heart failure (HF) manifests primarily as dyspnea, fatigue, and fluid retention, resulting in peripheral and pulmonary edema. Symptoms may vary depending on which ventricle is more affected, left or right.Left-Sided Heart FailureAlso known as left ventricular failure, this condition results from the left ventricle's inability to fill or eject sufficient blood into the systemic circulation. It leads to pulmonary congestion, which occurs when the left ventricle fails to eject blood effectively...
37
Imbalances in Cardiac Output01:26

Imbalances in Cardiac Output

The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
1.5K